Kovitz Investment Group Partners’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,888
Closed -$417K 837
2025
Q3
$417K Sell
2,888
-1,298
-31% -$177K ﹤0.01% 1095
2025
Q2
$530K Buy
4,186
+79
+2% +$9.7K ﹤0.01% 950
2025
Q1
$525K Sell
4,107
-32
-0.8% -$4.34K ﹤0.01% 888
2024
Q4
$547K Sell
4,139
-53
-1% -$7.45K ﹤0.01% 867
2024
Q3
$550K Buy
4,192
+1,154
+38% +$167K ﹤0.01% 740
2024
Q2
$417K Sell
3,038
-264
-8% -$35.2K ﹤0.01% 678
2024
Q1
$453K Sell
3,302
-448
-12% -$61.2K 0.01% 521
2023
Q4
$509K Sell
3,750
-119
-3% -$14.5K 0.01% 328
2023
Q3
$473K Buy
3,869
+3
+0.1% +$382 0.01% 332
2023
Q2
$491K Sell
3,866
-163
-4% -$21.2K 0.01% 340
2023
Q1
$520K Buy
4,029
+1,351
+50% +$177K 0.01% 344
2022
Q4
$352K Sell
2,678
-1,541
-37% -$199K 0.01% 349
2022
Q3
$493K Sell
4,219
-131
-3% -$16.3K 0.01% 324
2022
Q2
$512K Sell
4,350
-615
-12% -$73K 0.01% 336
2022
Q1
$647K Sell
4,965
-11,172
-69% -$1.46M 0.01% 325
2021
Q4
$2.44M Buy
16,137
+2,132
+15% +$330K 0.06% 198
2021
Q3
$2.26M Sell
14,005
-499
-3% -$84K 0.05% 223
2021
Q2
$2.37M Buy
14,504
+3,918
+37% +$604K 0.05% 224
2021
Q1
$1.59M Sell
10,586
-5,451
-34% -$866K 0.04% 231
2020
Q4
$2.43M Sell
16,037
-691
-4% -$98.8K 0.06% 192
2020
Q3
$2.27M Sell
16,728
-629
-4% -$85.3K 0.06% 187
2020
Q2
$2.37M Sell
17,357
-3,923
-18% -$500K 0.07% 173
2020
Q1
$2.29M Sell
21,280
-5,322
-20% -$613K 0.08% 162
2019
Q4
$3.21M Sell
26,602
-2,092
-7% -$233K 0.09% 153
2019
Q3
$2.85M Buy
28,694
+1,824
+7% +$191K 0.09% 158
2019
Q2
$2.93M Buy
26,870
+2,910
+12% +$310K 0.09% 159
2019
Q1
$2.68M Buy
+23,960
New +$2.63M 0.09% 165

Other funds holding IBB